FindTrial
Sign In

Effects of different ways of hemocoagulase agkistrodon using on perioperative blood loss in patients undergoing cardiac surgery

Effects of different ways of hemocoagulase agkistrodon using on perioperative blood loss in patients undergoing cardiac surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800018205
Enrollment
Unknown
Registered
2018-09-05
Start date
2018-09-05
Completion date
Unknown
Last updated
2018-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary heart disease

Interventions

vein Group:Use sulin intravenously
local group:use sulin partially
Combination group:combination of vein and local use of sulin

Sponsors

Beijing Chaoyang Hosipital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Aged 18-80 years old; BMI<30kg/m2; NYHA scales I to III; ASA scales II and III.

Exclusion criteria

Exclusion criteria: Preoperative LVEF40s, INR >1.25; Plt <150x10^9/ml; Hb <100 g/L.

Design outcomes

Primary

MeasureTime frame
intraoperative blood loss;Postoperative drainage;—

Secondary

MeasureTime frame
Intravenous hemoglobin content;Venous red blood cell content;—

Countries

China

Contacts

Public ContactAn-Shi Wu

Beijing Chaoyang Hosipital Affiliated to Capital Medical University

wuanshi8@sina.com+86 13511010883

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026